Lazard Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17K | Sell |
534
-2,124
| -80% | -$67.6K | ﹤0.01% | 2134 |
|
|
2025
Q1 | $77K | Buy |
+2,658
| New | +$77K | ﹤0.01% | 1879 |
|
|
2022
Q4 | – | Sell |
-3,061
| Closed | -$86K | – | 2360 |
|
|
2022
Q3 | $86K | Buy |
3,061
+7
| +0.2% | +$197 | ﹤0.01% | 1532 |
|
|
2022
Q2 | $67K | Buy |
3,054
+124
| +4% | +$2.72K | ﹤0.01% | 1677 |
|
|
2022
Q1 | $84K | Buy |
2,930
+805
| +38% | +$23.1K | ﹤0.01% | 1479 |
|
|
2021
Q4 | $69K | Buy |
2,125
+12
| +0.6% | +$390 | ﹤0.01% | 1590 |
|
|
2021
Q3 | $97K | Sell |
2,113
-517
| -20% | -$23.7K | ﹤0.01% | 1433 |
|
|
2021
Q2 | $144K | Buy |
2,630
+2,580
| +5,160% | +$141K | ﹤0.01% | 1266 |
|
|
2021
Q1 | $2K | Hold |
50
| – | – | ﹤0.01% | 1802 |
|
|
2020
Q4 | $2K | Buy |
+50
| New | +$2K | ﹤0.01% | 1799 |
|
|
2020
Q3 | – | Sell |
-2,341
| Closed | -$125K | – | 1597 |
|
|
2020
Q2 | $125K | Buy |
2,341
+263
| +13% | +$14K | ﹤0.01% | 975 |
|
|
2020
Q1 | $73K | Buy |
+2,078
| New | +$73K | ﹤0.01% | 1065 |
|
|
2019
Q1 | – | Sell |
-14,300
| Closed | -$659K | – | 1140 |
|
|
2018
Q4 | $659K | Hold |
14,300
| – | – | ﹤0.01% | 773 |
|
|
2018
Q3 | $1.1M | Sell |
14,300
-34,787
| -71% | -$2.68M | ﹤0.01% | 735 |
|
|
2018
Q2 | $4.13M | Buy |
49,087
+20,555
| +72% | +$1.73M | 0.01% | 589 |
|
|
2018
Q1 | $2.33M | Sell |
28,532
-10,604
| -27% | -$867K | ﹤0.01% | 632 |
|
|
2017
Q4 | $2.24M | Sell |
39,136
-13,523
| -26% | -$773K | ﹤0.01% | 625 |
|
|
2017
Q3 | $3.51M | Buy |
52,659
+23,179
| +79% | +$1.55M | 0.01% | 577 |
|
|
2017
Q2 | $1.52M | Buy |
+29,480
| New | +$1.52M | ﹤0.01% | 635 |
|